🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Central Nervous System Lymphoma

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy NCT03959085Phase 3231 sites📍 Birmingham📍 Mobile📍 Anchorage Children's Oncology Group · Tests: Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan Pembrolizumab, Ibrutinib and Rituximab in PCNSL NCT04421560Phase 1, Phase 24 sites📍 Boston📍 Boston📍 New York Dana-Farber Cancer Institute · Tests: Ibrutinib, Pembrolizumab, Rituximab PUMCH Dementia Longitudinal Cohort Study NCT05023564n/a1 site📍 Beijing Peking Union Medical College Hospital Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study) NCT07083154Phase 38 sites📍 Changsha📍 Changzhou📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Mazdutide, Placebo The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients. NCT05931328Phase 21 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: thiotepa combined with pomalidomide Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) NCT06362707Phase 26 sites📍 Tromsø📍 Oslo📍 Haugesund Helse Stavanger HF · Tests: Fasudil, Placebo IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) NCT07104032Phase 342 sites📍 Phoenix📍 Scottsdale📍 Fullerton Ono Pharmaceutical Co., Ltd. · Tests: Tirabrutinib, Rituximab, Temozolomide Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas NCT05681195Phase 21 site📍 Miami Baptist Health South Florida · Tests: Pemetrexed, Zanubrutinib, Autologous Stem Cell Transplant (ASCT), Whole Brain Radiation Therapy (WBRT) Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital NCT06560372NA1 site📍 Fort-de-France University Hospital Center of Martinique · Tests: Additional realization of a brain perfusion scan sequence which would allow the radiological diagnosis of CV Orelabrutinib, Sintilimab and Temozolomide in Relapsed or Refractory Central Nervous System Lymphoma NCT04961515Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Orelabrutinib, Sintilimab, Temozolomide (TMZ) NB02 (Poseltinib) Combined Rituximab and Lenalidomide in R/R PCNSL NCT06737250Phase 210 sites📍 Busan📍 Hwasun📍 Ilsan NOBO Medicine · Tests: R2P -> RP Dolutegravir Versus Dolutegravir in Combination With Tenofovir for the Treatment of HTLV-1 Infection NCT07555431Phase 21 site📍 Salvador Carlos Brites · Tests: Combination of Dolutegravir + Tenofovir DF for treatment of HTLV-1 infection, Dolutegravir (DTG) Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion NCT06333899EARLY Phase 118 sites📍 Aurora📍 Washington D.C.📍 Chicago Nationwide Children's Hospital · Tests: Lorlatinib, Lorlatinib with chemotherapy1, Lorlatinib with chemotherapy 2, Lorlatinib post Radiation Lenalidomide Maintenance Treatment in Patients With Primary Central Nervous System Lymphoma NCT05260619Phase 21 site📍 Seongnam-si Seoul National University Bundang Hospital · Tests: lenalidomide Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL NCT07749365Phase 21 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: hypofractionated radiotherapy plus GM-CSF, pomalidomide and glofitamab CLIMB: CNS Lymphoma Imaging and Molecular Biomarkers Study NCT05828628n/a1 site📍 Sutton Royal Marsden NHS Foundation Trust Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults NCT06664229NA1 site📍 Seoul Sunmi Song · Tests: Fall and dementia prevention exercise Cognitive Screening Made Easy for PCPs - Administrative Supplement NCT06928298NA3 sites📍 Austin📍 Austin📍 San Antonio University of Texas at Austin · Tests: RACS app Evaluation of CO-OP for Adolescents With Mild Intellectual Disability NCT06691698NA2 sites📍 Kristianstad📍 Karlstad Örebro University, Sweden · Tests: The Cognitive Orientation to Daily Occupational Performance Approach T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) NCT06343311Phase 1, Phase 25 sites📍 Sacramento📍 Cleveland📍 Portland Estrella Immunopharma, Inc. · Tests: EB103 Study of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL. NCT04627753Phase 21 site📍 Seoul Kim, Seok Jin · Tests: Rituximab, lenalidomide Chronic CED of TPT for Recurrent Malignant Glioma NCT06666712Phase 11 site📍 New York Jeffrey N. Bruce · Tests: Topotecan Zanubrutinib in Combination With Pola-R-CHP and High-dose Methotrexate in Patients With Secondary CNS Lymphoma NCT06730542Phase 11 site📍 Miami Juan P. Alderuccio, MD · Tests: Zanubrutinib, Methotrexate, Polatuzumab Vedotin, Rituximab, Cyclophosphamide Autonomic Involvement in Patient With Cognitive Decline NCT06292741NA1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Sudoscan Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic Malignancies NCT05011045n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Magnetic Resonance Imaging, Neurocognitive Assessment, Quality-of-Life Assessment, Questionnaire Administration Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL NCT02836158Phase 2, Phase 31 site📍 Beijing Navy General Hospital, Beijing · Tests: R-IDARAM plus intrathecal chemotherapy Diagnosis; Objective RespOnse; THErApy NCT05036564NA1 site📍 Milan IRCCS San Raffaele · Tests: Lumbar puncture cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881n/a17 sites📍 Duarte📍 Miami📍 Gainesville Adela, Inc A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies NCT04830137Phase 116 sites📍 Duarte📍 Orange📍 San Francisco Nurix Therapeutics, Inc. · Tests: NX-2127
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy